Status:
COMPLETED
Incretin Effect in Patients With Psoriasis and Controls
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Conditions:
Psoriasis Vulgaris
Eligibility:
All Genders
18-75 years
Brief Summary
To investigate the incretin effect and postprandial incretin responses in plasma in patients with psoriasis
Eligibility Criteria
Inclusion
- no diabetes BMI \< 27 kg/m\^2 normal Glucose tolerance test at screening normal fasting plasma glucose no islet auto antibodies no hormonel contraception informed consent psoriasis vulgaris (PASI\>8) (case not controls)
Exclusion
- other chronic inflammtory skin disease other chronic inflammatory disease pregnancy psychiatric illness
Key Trial Info
Start Date :
September 11 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 11 2015
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06064084
Start Date
September 11 2011
End Date
September 11 2015
Last Update
October 3 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.